We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week
Published in Oncology

Journal Scan / Research · October 09, 2014

Vemurafenib With Cobimetinib Improves Outcomes in Melanoma

The New England Journal of Medicine

 

Additional Info

The New England Journal of Medicine
Combined Vemurafenib and Cobimetinib in BRAF-Mutated Melanoma
N. Engl. J. Med 2014 Sep 29;[EPub Ahead of Print], J Larkin, PA Ascierto, B Dréno, V Atkinson, G Liszkay, M Maio, M Mandalà, L Demidov, D Stroyakovskiy, L Thomas, L de la Cruz Merino, C Dutriaux, C Garbe, MA Sovak, I Chang, GA McArthur, A Ribas, N Choong, SP Hack

Further Reading